The serum protein α2-Heremans-Schmid glycoprotein/ fetuin-A is a systemically acting inhibitor of ectopic calcification

Journal of Clinical Investigation

Volumn 112, Issue 3, 2003, Pages 357-366

  Schäfer, Cora ^a   Heiss, Alexander ^a   Schwarz, Anke ^b   Westenfeld, Ralf ^a   Ketteler, Markus ^a   Floege, Jürgen ^a   Müller Esterl, Werner ^c   Schinke, Thorsten ^d   Jahnen Dechent, Willi ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d University of Medical School Hamburg Eppendorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FETUIN; FETUIN A; MINERAL; PHOSPHATE; UNCLASSIFIED DRUG; VITAMIN D; ALPHA2HS GLYCOPROTEIN; PLASMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIFICATION; CALCINOSIS; CALCIUM HOMEOSTASIS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; EXTRACELLULAR FLUID; MINERALIZATION; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; DBA MOUSE; DIET; FEMALE; GENETICS; HUMAN; MALE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALS; BLOOD PROTEINS; CALCINOSIS; CALCIPHYLAXIS; DIET; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MINERALS; SPECIES SPECIFICITY; VITAMIN D;

EID: 85047694301     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17202     Document Type: Article

References (60)

1. Schinke, T., McKee, M.D., and Karsenty, G. 1999. Extracellular matrix calcification: where is the action? Nat. Genet. 21:150-151.
2. Luo, G., et al. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386:78-81.
3. Speer, M.Y., et al. 2002. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J. Exp. Med. 196:1047-1055.
4. Ho, A.M., Johnson, M.D., and Kingsley, D.M. 2000. Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 289:265-270.
5. Okawa, A., et al. 1998. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat. Genet. 19:271-273.
6. Bostrom, K., and Demer, L.L. 2000. Regulatory mechanisms in vascular calcification. Crit. Rev. Eukaryot. Gene Expr. 10:151-158.
7. Shanahan, C.M., et al. 2000. Expression of mineralisation-regulating proteins in association with human vascular calcification. Z. Kardiol. 89(Suppl. 2):63-68.
8. Le Saux, O., et al. 2000. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat. Genet. 25:223-227.
9. Munroe, P.B., et al. 1999. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat. Genet. 21:142-144.
10. Nakamura, I., et al. 1999. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum. Genet. 104:492-497.
11. Halverson, P.B. 1996. Calcium crystal-associated diseases. Curr. Opin. Rheumatol. 8:259-261.
12. Goodman, W.G., et al. 2000. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342:1478-1483.
13. Rosenhek, R., et al. 2000. Predictors of outcome in severe, asymptomatic aortic stenosis. N. Engl. J. Med. 343:611-617.
14. Faverly, D.R., Hendriks, J.H., and Holland, R. 2001. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 91:647-659.
15. Hackeng, T.M., Rosing, J., Spronk, H.M., and Vermeer, C. 2001. Total chemical synthesis of human matrix Gla protein. Protein Sci. 10:864-870.
16. Pedersen, K.O. 1944. Fetuin, a new globin isolated from serum. Nature. 154:575.
17. 2-Mukoids aus Humanserum. Naturwiss. 49:15-17.
18. 2-HS glycoprotein and fetuin. FEBS Lett. 227:167-170.
19. Olivier, E., et al. 2000. Fetuin-B, a second member of the fetuin family in mammals. Biochem. J. 350:589-597.
20. Dziegielewska, K.M., and Brown, W.M. 1995. Fetuin. Springer-Verlag. Heidelberg, Germany. 178 pp.
21. Terkelsen, O.B., et al. 1998. Rat fetuin: distribution of protein and mRNA in embryonic and neonatal rat tissues. Anat. Embryol. (Berlin) 197:125-133.
22. 2-HS glycoprotein and its uptake by bone tissue. Calcif. Tissue Res. 26:155-161.
23. 2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J. Biol. Chem. 271:20789-20796.
24. 2-HS glycoprotein/fecuin-A: formation of colloidal calciprotein particles. J. Biol. Chem. 278:13333-13341.
25. Jahnen-Dechent, W., et al. 1997. Cloning and targeted deletion of the mouse fetuin gene. J. Biol. Chem. 272:31496-31503.
26. Kovacs, C.S., and Kronenberg, H.M. 1997. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr. Rev. 18:832-872.
27. van den Broek, F.A., and Beynen, A.C. 1998. The influence of dietary phosphorus and magnesium concentrations on the calcium content of heart and kidneys of DBA/2 and NMRI mice. Lab. Anim. 32:483-491.
28. Parfitt, A.M., et al. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610.
29. Brunnert, S.R., Shi, S., and Chang, B. 1999. Chromosomal localization of the loci responsible for dystrophic cardiac calcinosis in DBA/2 mice. Genomics. 59:105-107.
30. Colinayo, V.V., et al. 2002. Genetic characterization of the Dyscalc locus. Mamm. Genome. 13:283-288.
31. Drueke, T.B. 2001. Genetic aspects of secondary hyperparathyroidism in uremia. Am. J. Kidney Dis. 38:S143-S146.
32. London, G.M., Pannier, B., Marchais, S.J., and Guerin, A.P. 2000. Calcification of the aortic valve in the dialyzed patient. J. Am. Soc. Nephrol. 11:778-783.
33. Blumenthal, N.C. 1989. Mechanisms of inhibition of calcification. Clin. Orthop. 247:279-289.
34. Angelis, M., Wong, L.L., Myers, S.A., and Wong, L.M. 1997. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery. 122:1083-1089; discussion 1089-1090.
35. Khafif, R.A., DeLima, C., Silverberg, A., and Frankel, R. 1990. Calciphylaxis and systemic calcinosis. Collective review. Arch. Intern. Med. 150:956-959.
36. Gilson, R.T., and Milum, E. 1999. Calciphylaxis: case report and treatment review. Cutis. 63:149-153.
37. Fine, A., and Zacharias, J. 2002. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 61:2210-2217.
38. Vasku, V., and Vasku, J. 2001. The development of the pathophysiological concept of calciphylaxis in experiment and clinic. Pathophysiology. 7:231-244.
39. Neuman, W.F. 1980. Bone material and calcification mechanisms. In Fundamental and clinical bone physiology. M.R. Urist, editor. J.B. Lippincott Co. Philadelphia, Pennsylvania, USA. 83-107.
40. Schinke, T., Koide, T., and Jahnen-Dechent, W. 1997. Human histidine-rich glycoprotein expressed in SF9 insect cells inhibits apatite formation. FEBS Lett. 412:559-562.
41. Price, P.A., et al. 2002. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J. Biol. Chem. 277:3926-3934.
42. Price, P.A., Caputo, J.M., and Williamson, M.K. 2002. Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. J. Bone Miner. Res. 17:1171-1179.
43. Price, P.A., and Lim, J.E. 2003. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J. Biol. Chem. 278:22144-22152.
44. Price, P.A., Nguyen, T.M., and Williamson, M.K. 2003. Biochemical characterization of the serum fetuin-mineral complex. J. Biol. Chem. 278:22153-22160.
45. Mathews, S.T., et al. 2002. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 51:2450-2458.
46. Szweras, M., et al. 2002. alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J. Biol. Chem. 277:19991-19997.
47. Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H.C., and Dennis, J.W. 1996. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J. Biol. Chem. 271:12755-12761.
48. Binkert, C., et al. 1999. Regulation of osteogenesis by fetuin. J. Biol. Chem. 274:28514-28520.
49. Demer, L.L. 1995. A skeleton in the atherosclerosis closet. Circulation. 92:2029-2032.
50. Shafritz, A.B., et al. 1996. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N. Engl. J. Med. 335:555-561.
51. 2-HS glycoprotein. Immunol. Commun. 3:329-335.
52. 2-HS glycoprotein is a potent and specific crystal-bound inhibitor. Arthritis Rheum. 31:1081-1089.
53. Hart, S.P., et al. 2003. Specific binding of an antigen-antibody complex to apoptotic human neutrophils. Am. J. Pathol. 162:1011-1018.
54. Baskies, A.M., et al. 1980. Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity. Cancer. 45:3050-3060.
55. Kalabay, L., et al. 1992. Diagnostic value of the determination of serum alpha2-HS-glycoprotein. Orv. Hetil. 133:1553-1554.
56. Kalabay, L., et al. 2002. Human fetuin/alpha2HS-glycoprotein level as a novel indicator of liver cell funccion and short-term mortality in patients with liver cirrhosis and liver cancer. Eur. J. Gastroenterol. Hepatol. 14:389-394.
57. Ketteler, M., et al. 2003. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 361:827-833.
58. Gorgani, N.N., Smith, B.A., Kono, D.H., and Theofilopoulos, A.N. 2002. Histidine-rich glycoprotein binds to DNA and Fc gamma RI and potentiates the ingestion of apoptotic cells by macrophages. J. Immunol. 169:4745-4751.
59. 2-HS glycoprotein is a negative acute-phase reactant. J. Clin. Invest. 64:1118-1129.
60. Miller, S., Vernon-Roberts, E., and McClure, J. 1984. Cutaneous calciphylactic reactions in the mouse and the rat and the effects of diphosphonates on the reaction in the rat. J. Pathol. 142:7-13.